BRPI0500727A - derivados 1-metil-3,6,7,8 - tetrahidropirazolo [3,4,-b] pirrolo [4,3-d] piridina-6,8-diona, processo de preparação, composições farmacêuticas contendo os mesmos e usos relacionados - Google Patents

derivados 1-metil-3,6,7,8 - tetrahidropirazolo [3,4,-b] pirrolo [4,3-d] piridina-6,8-diona, processo de preparação, composições farmacêuticas contendo os mesmos e usos relacionados

Info

Publication number
BRPI0500727A
BRPI0500727A BRPI0500727-5A BRPI0500727A BRPI0500727A BR PI0500727 A BRPI0500727 A BR PI0500727A BR PI0500727 A BRPI0500727 A BR PI0500727A BR PI0500727 A BRPI0500727 A BR PI0500727A
Authority
BR
Brazil
Prior art keywords
methyl
pharmaceutical compositions
compositions containing
pyrrolo
pyridine
Prior art date
Application number
BRPI0500727-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Ricardo Menegatti
Gisele Zapata-Sudo
Roberto Takashi Sudo
Eliezer De Jesus De L Barreiro
Carlos Alberto Manssour Fraga
Original Assignee
Univ Rio De Janeiro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rio De Janeiro filed Critical Univ Rio De Janeiro
Priority to BRPI0500727-5A priority Critical patent/BRPI0500727A/pt
Priority to PCT/BR2006/000037 priority patent/WO2006092032A2/fr
Publication of BRPI0500727A publication Critical patent/BRPI0500727A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0500727-5A 2005-03-03 2005-03-03 derivados 1-metil-3,6,7,8 - tetrahidropirazolo [3,4,-b] pirrolo [4,3-d] piridina-6,8-diona, processo de preparação, composições farmacêuticas contendo os mesmos e usos relacionados BRPI0500727A (pt)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BRPI0500727-5A BRPI0500727A (pt) 2005-03-03 2005-03-03 derivados 1-metil-3,6,7,8 - tetrahidropirazolo [3,4,-b] pirrolo [4,3-d] piridina-6,8-diona, processo de preparação, composições farmacêuticas contendo os mesmos e usos relacionados
PCT/BR2006/000037 WO2006092032A2 (fr) 2005-03-03 2006-03-03 Compositions pharmaceutiques comprenant des derives de 1-methyl-3,6,7,8-tetrahydropirazolo[3,4-b]pirrolo[4,3-d]pyridine-6,8-dione, leur utilisation et leurs procedes de preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0500727-5A BRPI0500727A (pt) 2005-03-03 2005-03-03 derivados 1-metil-3,6,7,8 - tetrahidropirazolo [3,4,-b] pirrolo [4,3-d] piridina-6,8-diona, processo de preparação, composições farmacêuticas contendo os mesmos e usos relacionados

Publications (1)

Publication Number Publication Date
BRPI0500727A true BRPI0500727A (pt) 2006-10-17

Family

ID=36941519

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0500727-5A BRPI0500727A (pt) 2005-03-03 2005-03-03 derivados 1-metil-3,6,7,8 - tetrahidropirazolo [3,4,-b] pirrolo [4,3-d] piridina-6,8-diona, processo de preparação, composições farmacêuticas contendo os mesmos e usos relacionados

Country Status (2)

Country Link
BR (1) BRPI0500727A (fr)
WO (1) WO2006092032A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201100423A (en) 2009-03-31 2011-01-01 Arqule Inc Substituted pyrazolo-pyrrolo-pyridine-dione compounds
CN110156775A (zh) * 2018-02-12 2019-08-23 新发药业有限公司 一种吡昔替尼的简便制备方法
RU2771024C1 (ru) * 2021-05-28 2022-04-25 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ и установка для изготовления диацетонитрила

Also Published As

Publication number Publication date
WO2006092032A3 (fr) 2006-11-02
WO2006092032B1 (fr) 2006-12-28
WO2006092032A2 (fr) 2006-09-08

Similar Documents

Publication Publication Date Title
BRPI0809998B8 (pt) composto de imidazo[1,2-a] piridina como inibidores do receptor tirosina quinase, seus usos, seus processos de preparação e composições farmacêuticas
BRPI0517796A (pt) compostos de imidazo[1,2-a]piridina, bem como processo para preparação, composição e uso dos mesmos
BRPI0905783A2 (pt) Composto, método pata travar uma perturbação cognitiva, perturbação psicótica, perturbação mediada por neurotransmissor ou uma perturbação neuronal em um indivíduo, composição farmacêutica e kit
BRPI0507852A (pt) 2-(piridin-3-ilamino)-pirido[2,3-d]pirimidin-7-onas
BR112012010041A2 (pt) derivados de imidazo [1,2-b] piridazina e seu uso como inibidores de pde10
BR0307057A (pt) 2-(piridin-2-ilamino)-pirido[2,3-d]pirimidin-7-onas
ECSP088413A (es) Preparación y uso de derivados de tetrahidropirrolo[3,2-c]piridin-4-ona para el tratamiento de la obesidad, trastornos psiquiátricos y neurológicos
MX2011005937A (es) Compuestos organicos.
BR112012022650A8 (pt) derivados de imidazo [1,2-a]pirazina e seu uso como inibidores de pde10
EA201691862A3 (ru) Имидазотриазины и имидазопиримидины в качестве ингибиторов киназы
MX2010006212A (es) Compuestos organicos.
CR10358A (es) Pirido[3,2-e] pirazinas, su uso como inhibidores de fosfodiesterasa 10, y procesos para prepararlos
BRPI0613859A8 (pt) compostos derivados de nitrocatecol, seu uso e seu processo de preparação, bem como composição farmacêutica
UA93043C2 (ru) ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ ДЛЯ ПОЛУЧЕНИЯ ТРАНС-5-ХЛОР-2-МЕТИЛ-2,3,3А,12В-ТЕТРАГИДРО-1Н-ДИБЕНЗ[2,3:6,7]ОКСЕПИНО[4,5-с]ПИРОЛА
EA201270498A1 (ru) 8-этил-6-(арил)пиридо[2,3-d]пиримидин-7(8h)-оны для лечения заболеваний цнс
BRPI0414541A8 (pt) compostos heterocíclicos fundidos, seu uso, método de preparação de compostos intermediários e método para estudar distúrbios mediados por serotonina
ECSP11011181A (es) Compuestos orgánicos
MX2010008719A (es) Pirrolo [2,-d] piridinas y usos de las mismas como inhibidores de cinasa de tirosina.
EA201170773A1 (ru) Органические соединения
BRPI0519760A2 (pt) derivados de pirrolidila de compostos heteroaromÁticos como inibidores de fosfodiesterasse
BR112012006639A2 (pt) métodos para preparar derivados de pirimidina úteis como inibidores de protéina quinase
NO20082511L (no) Nye pyridopyraziner og deres anvendelse som kinasemodulatorer
CR9643A (es) Derivados de n-(arilalquil)-1h-pirrolopiridina-2-carboxamidas, su preparacion y su aplicacion en terapeutica
BR112015000459A8 (pt) Inibidores da enzima fosfodiesterase 10, seu uso, composição farmacêutica que os compreende, seus processo de preparação e produto
BRPI0500727A (pt) derivados 1-metil-3,6,7,8 - tetrahidropirazolo [3,4,-b] pirrolo [4,3-d] piridina-6,8-diona, processo de preparação, composições farmacêuticas contendo os mesmos e usos relacionados

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07D Technical examination (opinion) related to article 229 of industrial property law
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 12A ANUIDADE.

B08G Application fees: restoration
B07E Notice of approval relating to section 229 industrial property law
B15K Others concerning applications: alteration of classification

Ipc: C07D 471/14 (2006.01), A61K 31/437 (2006.01), A61P

B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application according art. 36 industrial patent law
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements